Discover 1,072 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,072
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
for
Smith-Lemli-Opitz Syndrome
Location: Portland OR
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 0+
Code: NCT00004347
Phase2, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Boston MA, New Haven CT, Mineola NY, New York NY,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
for
Gastroparesis, Gastroparesis Nondiabetic,
Location: Tampa FL, Detroit MI, Louisville KY, Saint Louis MO,
Sponsor: Enterra Medical, Inc.
Sex: All
Age: 18 - 70
Code: NCT06560307
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Brewer ME, Manchester NH, Worcester MA, Concord NH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Boston MA, New York NY, Durham NC, Buffalo NY,
Location: Hartford CT, New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Endospan Ltd.
Sex: All
Age: 18+
Code: NCT04471909
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
Beat Childhood Cancer Specimen Banking and Data Registry
for
Pediatric Cancer, Survivorship
Location: Hartford CT, Norfolk VA, Hershey PA, Miami FL,
Sponsor: Giselle Sholler
Sex: All
Age: 0+
Code: NCT04715178
Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Shift Worker Intervention for Sleep Health
for
Shift Work Type Circadian Rhythm Sleep Disorder,
Location: Corvallis OR
Sponsor: Oregon State University
Sex: All
Age: 18 - 65
Code: NCT06384742
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
for
Small Cell Lung Cancer Extensive Stage
Location: Fairfax VA, Canton OH, Cincinnati OH, Fairfield OH,
Sponsor: Genprex, Inc.
Sex: All
Age: 18+
Code: NCT05703971
Phase1, Phase2, Recruiting
Observational Study of Corneal Opacities in Adults
for
Corneal Opacities (Scar and Stromal Dystrophy)
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18 - 70+
Code: NCT02109471
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Burlington MA, The Bronx NY, New Brunswick NJ,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase2, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Boston MA, Lebanon NH, New York NY, New Brunswick NJ,